中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共110条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract 期刊论文
CANCER COMMUNICATIONS, 2022
作者:  Wu, Huanwen;  Yu, Zicheng;  Liu, Yueping;  Guo, Lei;  Teng, Lianghong;  Guo, Lingchuan;  Liang, Li;  Wang, Jing;  Gao, Jie;  Li, Ruiyu;  Yang, Ling;  Nie, Xiu;  Su, Dan;  Liang, Zhiyong
收藏  |  浏览/下载：61/0  |  提交时间：2022/12/22
Neuroendocrine carcinomas  Gastrointestinal tract  Genomic characterization  Heterogeneity  Therapeutic implications  
Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Guo-Zhen;  Ma, Li-Ying;  Zhang, Zong-Hui;  Wang, Xiao-Lin;  Hua, Jing-Han;  Zhang, Jia-Hui;  Lv, Yang;  Zhang, Shao-Bo;  Ou, Jian;  Lin, Wen-Chu
收藏  |  浏览/下载：48/0  |  提交时间：2022/12/22
small-cell lung cancer  H3  3  PARP1  PARP inhibitor  darinaparsin  combination treatment  
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study 期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:  Wei, Jingwen;  Xiang, Jing;  Hao, Yue;  Si, Jinfei;  Wang, Wenxian;  Li, Fangyin;  Song, Zhengbo
收藏  |  浏览/下载：42/0  |  提交时间：2022/12/22
Anemia  Epidermal growth factor receptor  Epidermal growth factor receptor tyrosine kinase inhibitors  Non-small cell lung cancer  
Protein disulfide isomerase blocks the interaction of LC3II-PHB2 and promotes mTOR signaling to regulate autophagy and radio/chemo-sensitivity 期刊论文
CELL DEATH & DISEASE, 2022, 卷号: 13
作者:  Wang, Ruru;  Shang, Yajing;  Chen, Bin;  Xu, Feng;  Zhang, Jie;  Zhang, Zhaoyang;  Zhao, Xipeng;  Wan, Xiangbo;  Xu, An;  Wu, Lijun;  Zhao, Guoping
收藏  |  浏览/下载：41/0  |  提交时间：2022/12/22
Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Liu, Xin;  Fu, Meng;  Xia, Daqing;  Ji, Zimei;  Hu, Nana;  Leng, Zaijun;  Xie, Wang;  Fang, Yuan;  Zhang, Junqiang
收藏  |  浏览/下载：35/0  |  提交时间：2022/12/22
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study 期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:  Wang, Wenxian;  Lin, Gen;  Guan, Yelan;  Zhang, Yuxin;  Xu, Chunwei;  Wang, Qian;  Wang, Dong;  Jiang, Zhansheng;  Cai, Jing;  Lou, Guangyuan;  Song, Zhengbo;  Zhang, Yongchang
收藏  |  浏览/下载：36/0  |  提交时间：2022/12/23
Thymic carcinoma  Immunotherapy  PD-1  Efficacy  Immune-related adverse events  
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载：51/0  |  提交时间：2022/12/22
HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies  
Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Zhang, Jiawei;  Wu, Yinan;  Mu, Jiayi;  Xin, Dijia;  Wang, Luyao;  Fan, Yili;  Zhang, Suzhan;  Xu, Yang
收藏  |  浏览/下载：39/0  |  提交时间：2022/12/22
colorectal cancer  glycosyltransferase  lncRNAs  risk model  overall survival  
Hub genes for early diagnosis and therapy of adamantinomatous craniopharyngioma 期刊论文
MEDICINE, 2022, 卷号: 101
作者:  Zou, Yang-Fan;  Zhang, Shu-Yuan;  Li, Li-Weng;  Jing, Kai;  Xia, Liang;  Sun, Cai-Xing;  Wu, Bin
收藏  |  浏览/下载：46/0  |  提交时间：2022/12/22
adamantinomatous craniopharyngioma  biological information technology  biomarker  differentially expressed genes  
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study 期刊论文
CANCERS, 2022, 卷号: 14
作者:  Xie, Mingying;  Li, Na;  Xu, Xiaoling;  Xu, Yanjun;  Li, Hui;  Zhu, Liang;  Sheng, Jiamin;  Zhou, Zichao;  Fan, Yun
收藏  |  浏览/下载：40/0  |  提交时间：2022/12/22
liver metastasis  non-small cell lung cancer  PD-L1  PD-1  PD-L1 inhibitor  CD8+T cell